Annual Cash & Cash Equivalents
$4.57B$5.80B-55.93%
Summary
- Current Value
- As of today, VRTX annual cash & cash equivalents is $4.57B, down -55.93% on
- Historical Performance
- VRTX annual cash & cash equivalents is down -32.75% over the past 3 years, and up +46.96% over the past 5 years
- All-Time High Comparison
- VRTX annual cash & cash equivalents is currently -56.50% below its historical high of $10.50B set on
- 3-Year Low Comparison
- VRTX annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- VRTX annual cash & cash equivalents is higher than 97.88% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.57B | -55.9% | -32.8% | +47.0% | +923.1% | |
| Quarterly Cash & Cash Equivalents | $6.30B | -3.6% | -35.6% | +2.3% | +423.3% | |
| Price | $454.67 | +10.0% | +51.1% | +100.2% | +1079.4% | |
| Annual Current Assets | $9.60B | -32.1% | +0.4% | +99.0% | +634.2% | |
| Annual Total Liabilities | $6.68B | +21.3% | +100.5% | – | +677.6% | |
| Annual Working Capital | $6.03B | -43.1% | -18.7% | +72.9% | +490.1% | |
| Annual Net Income | -$535.60M | -114.8% | -122.9% | -145.5% | +16.6% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $10.50B | N/A | -56.5% |
| 5Y | $10.50B | -56.5% | |
| All | $10.50B | -56.5% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.57B | at low | |
| 5Y | $4.57B | at low | |
| All | $4.40M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of VRTX?
As of today, VRTX annual cash & cash equivalents is $4.57B
What is 1-year change in VRTX annual cash & cash equivalents?
VRTX annual cash & cash equivalents is down -55.93% year-over-year
What is 3-year change in VRTX annual cash & cash equivalents?
VRTX annual cash & cash equivalents is down -32.75% over the past 3 years
How far is VRTX annual cash & cash equivalents from its all-time high?
VRTX annual cash & cash equivalents is currently -56.50% below its historical high of $10.50B set on December 31, 2022
How does VRTX annual cash & cash equivalents rank versus sector peers?
VRTX annual cash & cash equivalents is higher than 97.88% of companies in Healthcare sector
When is VRTX next annual earnings release?
The next annual earnings release for VRTX is on
Quarterly Cash & Cash Equivalents
$6.30B$97.40M-1.52%
Summary
- Current Value
- As of today, VRTX quarterly cash & cash equivalents is $6.30B, down -1.52% on
- Historical Performance
- VRTX quarterly cash & cash equivalents is down -3.65% year-over-year, and down -35.61% over the past 3 years
- All-Time High Comparison
- VRTX quarterly cash & cash equivalents is currently -47.25% below its historical high of $11.93B set on
- 3-Year Low Comparison
- VRTX quarterly cash & cash equivalents is +8.62% above its 3-year low of $5.80B reached on
- Sector Comparison
- VRTX quarterly cash & cash equivalents is higher than 98.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $6.30B | -1.5% | -3.6% | -35.6% | +2.3% | |
| Annual Cash & Cash Equivalents | $4.57B | – | -55.9% | -32.8% | +47.0% | |
| Price | $454.67 | +11.6% | +10.0% | +51.1% | +100.2% | |
| Quarterly Current Assets | $10.57B | +1.4% | +7.8% | -13.9% | +41.7% | |
| Quarterly Total Liabilities | $7.54B | +9.9% | +14.1% | +105.2% | +138.1% | |
| Quarterly Working Capital | $6.09B | -3.1% | +4.5% | -36.9% | +11.7% | |
| Quarterly Net Income | $1.08B | +4.8% | +3.6% | +16.4% | +62.3% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $6.39B | -1.5% | |
| 3Y | $11.93B | -47.3% | |
| 5Y | $11.93B | -47.3% | |
| All | $11.93B | -47.3% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $6.12B | N/A | +2.9% |
| 3Y | $5.80B | +8.6% | |
| 5Y | $5.80B | +8.6% | |
| All | $2.30M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of VRTX?
As of today, VRTX quarterly cash & cash equivalents is $6.30B
What is VRTX quarterly cash & cash equivalents most recent change?
VRTX quarterly cash & cash equivalents was down -1.52% on September 30, 2025
What is 1-year change in VRTX quarterly cash & cash equivalents?
VRTX quarterly cash & cash equivalents is down -3.65% year-over-year
How far is VRTX quarterly cash & cash equivalents from its all-time high?
VRTX quarterly cash & cash equivalents is currently -47.25% below its historical high of $11.93B set on September 30, 2023
How does VRTX quarterly cash & cash equivalents rank versus sector peers?
VRTX quarterly cash & cash equivalents is higher than 98.46% of companies in Healthcare sector
When is VRTX next earnings release?
The next earnings release for VRTX is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- VRTX Official Website www.vrtx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875320/000087532025000232/0000875320-25-000232-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532025000053/0000875320-25-000053-index.htm
- VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
- VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx